Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic gluconeogenesis is promoted by the PKA-mediated phosphorylation of the cAMP response element-binding protein, which in turn upregulates peroxisome proliferator-activated receptor-γ coactivator (PGC)-1.160 Together with the hepatocyte nuclear factor (HNF)-4, PGC-1 induces the transcription of phosphoenolpyruvate carboxykinase,161 which catalyzes the conversion of oxaloacetate into phosphoen”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [161]
In the citing paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [24]
In the citing paper
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
In the citing paper
“The metabolic shifts that occur in response to fasting highlight the non-equivalence of PGC-1α function in distinct tissues.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“The liver-specific insulin-receptor knockout (LIRKO) mouse is a unique model of hepato-specific insulin resistance in the liver, and is associated with impaired glucose tolerance and the failure of insulin to suppress hepatic glucose productio”
BackgroundSelf-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“This region of PGC-1 has previously been shown to mediate ligand-dependent interactions with the activation function-2 (AF-2) domains of several nuclear receptors, including oestrogen receptor-α (ERα), peroxisome proliferator-activated receptor-α (PPARα) and glucocorticoid recepto”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Glycogenolysis occurs more rapidly, beginning within 2–3 h after a meal in humans, but gluconeogenesis assumes a much greater importance with prolonged fastin”
BackgroundSelf-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“PGC-1 coactivates HNF-4α and the glucocorticoid receptor The mechanisms underlying the transcriptional activation of the gluconeogenic enzyme PEPCK have been extensively studie”
Background(1997) · Diabetes reviews · Cited by 671
Cited by
Items 901–1,000 of 1,002
Gene-altered Mice and Metabolic Flux Control
Magnuson, M. A., She, P., & Shiota, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300020200 · Cited by 40
Mechanisms of basal and kinase-inducible transcription activation by CREB
Quinn, P. G. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72072-2 · Cited by 37
Potential regulatory role of the farnesoid X receptor in the metabolic syndrome
Durán-Sandoval, D., Cariou, B., Fruchart, J., & Staels, B. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.018 · Cited by 42
Asensio, C., Jimenez, M., Kühne, F., Rohner-Jeanrenaud, F., & Muzzin, P. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3490 · Cited by 36
Mamedova, L. K., Yuan, K., Laudick, A. N., Fleming, S. D., Mashek, D. G., & Bradford, B. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.009 · Cited by 37
“Recently, p38 MAPK was identified as a critical signaling component in FFA-induced transcription of key gluconeogenic genes and regulators, including PKC1, G6PC and peroxisome proliferator-activated-γ receptor coactivator α, an important stimulator of hepatic GNG [47] as well as PKC1 promoter activation [26].”
BackgroundPCAF fine‐tunes hepatic metabolic syndrome, inflammatory disease, and cancer
Wang, T., Yao, W., Shao, Y., Zheng, R., & Huang, F. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13877 · Cited by 37
Chen, P., Wu, X., Gu, X., Han, J., Xue, M., & Liang, X. (2021) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2021.113811 · Cited by 36
Zheng, H., Wan, J., Shan, Y., Song, X., Jin, J., Su, Q., Chen, S., Lu, X., Yang, J., Li, Q., et al. (2021) · Theranostics · doi:10.7150/thno.46882 · Cited by 38
“It has been well-established that mRNA expressions of PEPCK and G6Pase are tightly regulated by several transcriptional factors and coregulators, such as FoxO1 [5], HNF4α [6], CREB [7], GR [8], PGC-1α [9], CRTC2 [10], SIRT1 [11], and SRC-1 [12].”
Glucagon, cyclic AMP, and hepatic glucose mobilization: A half‐century of uncertainty
Rodgers, R. L. (2022) · Physiological Reports · doi:10.14814/phy2.15263 · Cited by 38
“Although fasting for 6 h increased plasma glucagon levels into zone 2, from 18 to 87 pM, it did not alter hepatic G6Pase activity in mice (Mutel et al., 2011).”
BackgroundInfluentialAltered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity
Kudo, T., Shimada, T., Toda, T., Igeta, S., Suzuki, W., Ikarashi, N., Ochiai, W., Ito, K., Aburada, M., & Sugiyama, K. (2009) · Xenobiotica · doi:10.1080/00498250903242592 · Cited by 38
Metabolic actions of FGF21: molecular mechanisms and therapeutic implications
Ge, X., Wang, Y., Lam, K. S., & Xu, A. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.011 · Cited by 41
FoxO6 and PGC-1α form a regulatory loop in myogenic cells
Chung, S. Y., Huang, W. C., Su, C.-W., Lee, K. W., Chi, H. C., Lin, C. T., Chen, S.-T., Huang, K., Tsai, M.-S., Yu, H. P., et al. (2013) · Bioscience Reports · doi:10.1042/bsr20130031 · Cited by 39
The role of transcriptional regulators in central control of appetite and body weight
Coppari, R., Ramadori, G., & Elmquist, J. K. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1070 · Cited by 41
Felder, T. K., Soyal, S. M., Oberkofler, H., Hahne, P., Auer, S., Weiss, R., Gadermaier, G., Miller, K. N., Krempler, F., Esterbauer, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227496 · Cited by 39
Wilson, C. G., Schupp, M., Burkhardt, B. R., Wu, J., Young, R., & Wolf, B. A. (2010) · Endocrinology · doi:10.1210/en.2010-0379 · Cited by 39
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia
Chapagain, A., Caton, P., Kieswich, J. E., Andrikopoulos, P., Nayuni, N. K., Long, J. H., Harwood, S., Webster, S. P., Raftery, M., Thiemermann, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312436111 · Cited by 36
“PGC1α mRNA and protein levels were also increased in SNx (Fig.”
BackgroundInfluentialRole of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis
Chen, J., Zhang, Z., Wang, N., Guo, M., Chi, X., Pan, Y., Jiang, J., Niu, J., Ksimu, S., Li, J. Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06328-3 · Cited by 37
Zhang, S., Lu, W., Yan, L., Mu-chao, W., Xu, M., Chen, L., & Cheng, H. (2007) · PubMed · Cited by 40
Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice
Tamura, Y., Ogihara, T., Uchida, T., Ikeda, F., Kumashiro, N., Nomiyama, T., Sato, F., Hirose, T., Tanaka, Y., Mochizuki, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0467-1 · Cited by 39
“Because the expression of PGC-1α is markedly increased in the liver of diabetic rodents, such an increase could be involved in the mechanism of hyperglycaemia in type 2 diabetes [26, 27].”
BackgroundInfluentialGrempler, R., Kienitz, A., Werner, T., MEYER, M., Barthel, A., AILETT, F., Sutherland, C. D., Walther, R., & Schmoll, D. (2004) · Biochemical Journal · doi:10.1042/bj20040160 · Cited by 42
Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again
Shuldiner, A. R., & McLenithan, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23586 · Cited by 42
“and in liver, PGC-1α is a pivotal regulator of gluconeogenesis (25).”
BackgroundStudies on lipoate effects on blood redox state in human immunodeficiency virus infected patients.
Fuchs, J., Schöfer, H., Milbradt, R., Freisleben, H., Buhl, R., Siems, W., & Grune, T. (1993) · PubMed · Cited by 40
Resveratrol Suppresses T0901317-Induced Hepatic Fat Accumulation in Mice
Gao, M., & Liu, D. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9473-7 · Cited by 35
Energy dysfunction in Huntington’s disease: insights from PGC-1α, AMPK, and CKB
Ju, T., Lin, Y., & Chern, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1025-2 · Cited by 42
“For example, FOXO1 and HNF-4a modulate genes of gluconeogenesis [55, 58].”
BackgroundSirtuins and Pyridine Nucleotides
Abdellatif, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.246546 · Cited by 36
Xu, Y., Luo, Z., Wu, K., Fan, Y.-F., You, W., & Zhang, L.-H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112405 · Cited by 35
“AAGCAAGAAG GCAATAGGGT GACCCATGTA AACCTAATCT GAAATTTAAA TGAGGATTGA GCCAGTAAAA CTCAGATAAA CAACATTTCA AATTCGGACC -2596 ATTCTCTGTG GCATTGCAAG TATCTCCGGC AAATCCCTCA GCACAGATGC AGAAGAAGGG ATCTTCTCCA ATGCCAGTCA CACATGTCCC TCCGTTGTGA -2496 CACAGGTTCA CCTTGCAGTA ATCTCCTATA GAGACACACA TAAGCAGGAG TGAATGGAAT TACAAAGATT AGACTGGAAT…”
BackgroundInfluentialSepa-Kishi, D. M., Katsnelson, G., Bikopoulos, G. J., Iqbal, A., & Ceddia, R. B. (2018) · Physiological Reports · doi:10.14814/phy2.13592 · Cited by 37
“This is particularly relevant to the full transcriptional activation of the PEPCK promoter and enhancement of gluconeogenesis that requires coactivation by PGC-1a of the liver-enriched transcription factor HNF4a (Yoon et al. 2001).”
BackgroundLee, J.-M., Han, H.-S., Jung, Y. S., Harris, R. A., Koo, S., & Choi, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002196 · Cited by 35
“In the liver, PGC-1 increases the expression of PEPCK and G6Pase via direct interaction with transcription factors including hepatocyte nuclear factor 4 (HNF4 ), FOXO1, and glucocorticoid receptor (GR) (7, 8).”
BackgroundWan, X., Zhu, X., Wang, H., Feng, Y., Zhou, W., Liu, P., Shen, W., Zhang, L., Liu, L., Li, T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902476r · Cited by 35
Zhao, Q., Zhang, J., & Wang, H. (2015) · Bioscience Reports · doi:10.1042/bsr20150112 · Cited by 36
Benton, C. R., Han, X.-X., Febbraio, M., Graham, T. E., & Bonen, A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00781.2005 · Cited by 33
“, PEPCK, G-6-Pase) (29, 50, 67) and muscle glucose transport (42).”
Nakatsu, Y., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Horike, N., Yoneda, M., Ohno, H., Tsuchiya, Y., Kamata, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137836 · Cited by 38
Zhang, K., Huang, Q., Dai, X., Yin, J., Zhang, W., Zhou, G., Zhou, G., & Liu, Z. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009355159 · Cited by 35
“PPARGC1A is involved in the regulation of fatty acid oxidation, skeletal muscle fiber type specificity, and gluconeogenesis.(1,2) Linkage analysis has reported marked associations of PPARGC1A genomic region on 4p with fasting serum insulin concentrations in Pima Indians(3) and body mass index (BMI) in Mexican American…”
BackgroundVaughan, R. A., Mermier, C. M., Bisoffi, M., Trujillo, K. A., & Conn, C. A. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0301-4 · Cited by 34
“in respiratory chain components [80, 112, 125].”
BackgroundDaniels, L. J., Kay, D., Marjot, T., Hodson, L., & Ray, D. W. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00551.2022 · Cited by 37
CD38-mediated Ca2+ signaling contributes to glucagon-induced hepatic gluconeogenesis
Rah, S., & Kim, U. (2015) · Scientific Reports · doi:10.1038/srep10741 · Cited by 34
Latorre‐Muro, P., Burgos, C., Hidalgo, J., Varona, L., Carrodeguas, J. A., & López‐Buesa, P. (2016) · Scientific Reports · doi:10.1038/srep19617 · Cited by 42
da Silva Teixeira, S., Filgueira, C., Sieglaff, D. H., Benod, C., Villagomez, R., Minze, L. J., Zhang, A., Webb, P., & Nunes, M. T. (2017) · Acta Physiologica · doi:10.1111/apha.12821 · Cited by 34
“Likewise, we were unable to detect changes in markers insulin response in liver; 3,5-T2 did not lead to hepatic AKT or GSK-3 phosphorylation and actually reduced hepatic glycogen content (Yoon et al. 2001, Schultze et al. 2011, Bogan 2012).”
ResultHS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter
Xu, X., Shi, X., Chen, Y., Zhou, T., Wang, J., Xu, X. Y., Chen, L., Hu, L., & Shen, X. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.016 · Cited by 34
Glycerol kinase interacts with nuclear receptor NR4A1 and regulates glucose metabolism in the liver
Miao, L., Yang, Y., Liu, Y., Lai, L., Wang, L., Zhan, Y., Yin, R., Yu, M., Li, C., Yang, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201800945rr · Cited by 34
Chen, Y., Wang, D., Yan, P., Yan, S., Chang, Q., & Cheng, Z. (2019) · Biology of Sport · doi:10.5114/biolsport.2019.88752 · Cited by 37
“PGC1 regulates the expression of several key genes involved in glucose and fatty acid oxidation [8, 9].”
BackgroundLiver lipid molecules induce PEPCK-C gene transcription and attenuate insulin action
Chen, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.108 · Cited by 34
“The transcription factors and co-activators that interact with these elements and regulate PEPCK-C gene transcription have been proposed or identified [8,11,12].”
BackgroundSelf-citationKim, Y. D., Kim, S., Hwang, S., Choi, H.-S., Bae, J., Song, D., & Im, S. (2014) · Diabetes · doi:10.2337/db13-1368 · Cited by 35
“Interestingly, while overexpression of Hnf-4a, GR, and Pgc-1a genes significantly increases the promoter activities of Pck1 and G6pc, which is consistent with previous reports (4,5,7,9).”
ResultReduced Insulin Receptor Expression Enhances Proximal Tubule Gluconeogenesis
Pandey, G., Shankar, K., Makhija, E., Gaikwad, A. N., ECELBARGER, C. A., Mandhani, A., Srivastava, A., & Tiwari, S. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25632 · Cited by 35
PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism
Lee, J., Hernández, M. A. S., Auen, T., Mucka, P., Lee, J., & Özcan, U. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.010 · Cited by 36
“While in healthy conditions this mechanism is beneficial for regulation of blood glucose levels, in obesity, hepatic PGC-1a expression is highly increased, and this up-regulation has previously shown to contribute to the increased hepatic glucose production and consequently to the hyperglycemia [24,27,35].”
BackgroundInfluentialKim, J. H., Ko, H. Y., Wang, H. J., Lee, H., Yun, M., & Kang, E. S. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13905 · Cited by 34
“Recent studies also showed that NAD-dependent deacetylase sirtuin-1 (SIRT1) interacts with and deacetylates peroxisome proliferative activated receptor-gamma co-activator 1α (PGC1α or PPARGC1), leading to induction of gluconeogenic gene expression in the liver.(21,22) In addition, SGLT2 inhibitors increase SIRT1 expre…”
BackgroundVohl, M., Houde, A., Lebel, S., Hould, F., & Marceau, P. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.07.002 · Cited by 36
Nachar, A., Vallerand, D., Musallam, L., Lavoie, L., Badawi, A. F., Arnason, J. T., & Haddad, P. S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/189819 · Cited by 33
“The expression of this enzyme is enhanced by several transcription factors such as forkhead transcription factor O1 (FoxO1), hepatic nuclear factor 4 (HNF4), and peroxisome proliferator-activated receptor-𝛾 coactivator-1𝛼 (PGC-1𝛼) [29, 30].”
BackgroundYang, M., Deng, K., Pan, M., Gu, Z., Liu, D., Zhang, Y., Zhang, W., & Mai, K. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.12.003 · Cited by 35
Liu, X., Wang, Y., & Ortlund, E. A. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116806 · Cited by 37
“Indeed, PGC1a can coactivate both GR and hepatic nuclear factor-4a to increase transcriptional activation of phosphoenolpyruvate carboxykinase, the rate-limiting enzyme in gluconeogenesis (Yoon et al., 2001).”
BackgroundGenetic characteristics of competitive swimmers: a review
Ben‐Zaken, S., Eliakim, A., Nemet, D., Kaufman, L., & Meckel, Y. (2021) · Biology of Sport · doi:10.5114/biolsport.2022.102868 · Cited by 35
“PGC1 regulates the expres - sion of several key genes involved in glucose and fatty acid oxida - tion [109, 110].”
BackgroundSeo, W. D., Lee, J. H., Jia, Y., Wu, C., & Lee, S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.057 · Cited by 33
Xu, C., Chakravarty, K., Kong, X., Tuy, T. T., Arinze, I., Bone, F., & Massillon, D. (2007) · Journal of Nutrition · doi:10.1093/jn/137.3.554 · Cited by 35
PXR cross-talks with internal and external signals in physiological and pathophysiological responses
Kodama, S., & Negishi, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.795585 · Cited by 34
“In addition, the two genes are also transactivated by HNF4a in a complex with PGC1a (Rhee et al., 2003; Yoon et al., 2001).”
BackgroundInfluentialGSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1
Sakamaki, J.-I., Daitoku, H., Kaneko, Y., Hagiwara, A., Ueno, K., & Fukamizu, A. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.660531 · Cited by 38
“levels of PGC-1α, a transcriptional coactivator that coordinately acts with HNF4α and FOXO1 to augment G6Pase and PEPCK transcription (4,5,28), was also decreased in GSK3β knockdown cells (Figure 1D).”
BackgroundParvaiz, F., Manzoor, S., Iqbal, J., Sarkar-Dutta, M., Imran, M., & Waris, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12361 · Cited by 33
Nervina, J. M., Magyar, C. E., Pirih, F. Q. M., & Tetradis, S. (2006) · Bone · doi:10.1016/j.bone.2006.04.023 · Cited by 34
“Our finding that PTH induced PGC-1αmRNA levels through cAMPPKA signaling in osteoblasts is consistent with reports that PGC1α is cAMP-responsive in other cells [11,12,51].”
ResultApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
Stein, S., Lohmann, C., Handschin, C., Stenfeldt, E., Borén, J., Lüscher, T. F., & Matter, C. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013539 · Cited by 35
“PGC-1a is an important cofactor in the transcriptional regulation of genes encoding metabolic enzymes and mitochondrial proteins [3], and it is interacting with many different transcription factors, such as peroxisome proliferator activated receptors (PPARs, including PPARa, PPARb/d, and PPARc), Liver X receptor a and…”
ppargc1a controls nephron segmentation during zebrafish embryonic kidney ontogeny
Chambers, J. M., Poureetezadi, S. J., Addiego, A., Lahne, M., & Wingert, R. A. (2018) · eLife · doi:10.7554/elife.40266 · Cited by 33
Tavares, C. D. J., Aigner, S., Sharabi, K., Sathe, S., Mutlu, B., Yeo, G. W.-M., & Puigserver, P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000643117 · Cited by 33
“For example, PGC-1 α binds to ERR α , NRFs, and YY1 to activate transcription of a large number of nuclear genes encoding for mitochondrial proteins (10, 11, 16, 17), or to HNF4 α , FOXO1, and GR to augment transcription of gluconeogenic genes (2, 18 – 20).”
BackgroundSelf-citationLeng, Y., Ren, L., Niu, S., Zhang, T., & Zhang, J. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112413 · Cited by 32
Transcriptional control of circadian metabolic rhythms in the liver
Li, S., & Lin, J. D. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12520 · Cited by 33
“Previous studies have established hepatic nuclear factor 4α (HNF4α), glucocorticoid receptor (GR) and forkhead box O1 (FoxO1) as key mediators of gluconeogenic gene regulation by PGC-1α [38,56].”
BackgroundInsulin's expanding control of forkheads
Czech, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135308100 · Cited by 35
Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
Cheung, B. M. Y., & Deng, H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.904745 · Cited by 35
“FGF21 mediates these actions via upregulation of PPAR-g coactivator-1a leading to increases in the transcription levels of various genes involved in glucose and lipid metabolism [30].”
BackgroundBruns, I., Sauer, B., Burger, M. C., Eriksson, J. A., Hofmann, U., Braun, Y., Harter, P. N., Luger, A., Ronellenfitsch, M. W., Steinbach, J. P., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006993 · Cited by 35
Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells
Yun, C. W., Lee, J. H., & Lee, S. H. (2019) · Anticancer Research · doi:10.21873/anticanres.13672 · Cited by 35
Reynolds, T., Banerjee, S., Sharma, V. M., Donohue, J., Couldwell, S., Sosinsky, A. Z., Frulla, A. P., Robinson, A., & Puri, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130259 · Cited by 34
“In the liver, PGC-1α plays an important role in promoting the expression of genes involved with gluconeogenesis during fasting [39].”
BackgroundZamora, M., Pardo, R., & Villena, J. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.032 · Cited by 34
Rocha, J. S., Bonkowski, M. S., França, L. R., & Bartke, A. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.02.001 · Cited by 33
Goyenechea, E., Crujeiras, A. B., Abete, I., Parra, D., & Martínez, J. A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.011 · Cited by 32
“[7] J.”
Sadana, P., Zhang, Y., Song, S., Cook, G. A., Elam, M. B., & Park, E. A. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.11.012 · Cited by 32
“It has been shown that PGC-1α induces the PEPCK and G6Pase genes which are involved in hepatic gluconeogenesis [36].”
BackgroundMcCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.034 · Cited by 36
ZHANG, S.-L., Lu, W., Yan, L., Mu-chao, W., Xu, M.-T., Li-hong, C. H. E. N., & Cheng, H. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200711010-00005 · Cited by 33
Mitogen-activated protein kinase pathway
(2004) · Springer eBooks · doi:10.1007/3-540-29662-x_1853 · Cited by 32
Yarushkin, A. A., Качайло, Е. М., & Pustylnyak, V. O. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12090 · Cited by 34
“HNF-4a is central to glucose metabolism because it is a key positive regulator of the basal hepatic expression of PEPCK and G6Pase genes (Yoon et al., 2001).”
BackgroundTungstate Reduces the Expression of Gluconeogenic Enzymes in STZ Rats
Nocito, L., Zafra, D., Calbó, J., Domínguez, J. E., & Guinovart, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042305 · Cited by 32
“After incubating the cells overnight in serum- and glucose-free DMEM, the medium was replaced with 3 ml of glucose production buffer consisting of glucose-free DMEM supplemented with 20 mM sodium lactate and 2 mM sodium pyruvate [12].”
MethodMitochondria and diabetes mellitus: untangling a conflictive relationship?
Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., Ogier de Baulny, H., & Rustin, P. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1263-0 · Cited by 34
“In humans with T2D, the ability of insulin to inhibit hepatic gluconeogenesis is impaired (Petersen and Shulman 2006); and in T2D animal models, liver PGC-1a expression is elevated (Herzig et al. 2001; Koo et al. 2004; Saltiel and Kahn 2001; Yoon et al. 2001).”
BackgroundInfluentialTankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice
Wang, H., Kuusela, S., Rinnankoski‐Tuikka, R., Dumont, V., Bouslama, R., Ramadan, U. A., Waaler, J., Linden, A.-M., Chi, N., Krauss, S. J. K., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0573-z · Cited by 32
Taghvaei, S., Saremi, L., & Babaniamansour, S. (2021) · PPAR Research · doi:10.1155/2021/5544233 · Cited by 31
“In addition, it increases the gene expression of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, which is vital for hepatic gluconeogenesis [10].”
BackgroundLiu, G., Feng, S., Yan, J., Luan, D., Sun, P., & Shao, P. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.09.001 · Cited by 31
Oliveri, L. M., Davio, C. A., Batlle, A. M. D. C., & Gerez, E. N. (2012) · Biochemical Journal · doi:10.1042/bj20111005 · Cited by 31
Zhang, H., Qi, L., Qiao, J., & Mao, L. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.02.039 · Cited by 31
Rodrigue‐Way, A., Demers, A., Ong, H., & Tremblay, A. (2006) · Endocrinology · doi:10.1210/en.2006-0975 · Cited by 40
Arpiainen, S., Järvenpää, S.-M., Manninen, A., Viitala, P., Lang, M. A., Pelkonen, O., & Hakkola, J. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.001 · Cited by 33
Uptake and metabolic effects of 3-iodothyronamine in hepatocytes
Ghelardoni, S., Chiellini, G., Frascarelli, S., Saba, A., & Zucchi, R. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0311 · Cited by 31
“…T 1 AM (0.1, 0.5, 1, 5, and 10 m M) or TA1 (0.5 and 1 m M) in 1 ml DMEM base, glucose-and phenol red-free, containing 100 U/ml penicillin, 100 m g/ml streptomycin, and 4 mM L -glutamine, supplemented with 2 mM sodium pyruvate and 20 mM sodium lactate (glucose production buffer; Yoon et al .”
InfluentialIwahashi, H., Yamagata, K., Yoshiuchi, I., Terasaki, J., Yang, Q., Fukui, K., Ihara, A., Zhu, Q., Asakura, T., Cao, Y., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.910 · Cited by 31
The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice
Cui, Y., Qiao, A., Jiao, T., Zhang, H., Xue, Y., Zou, Y., Cui, A., Fang, F., & Chang, Y. (2016) · Diabetologia · doi:10.1007/s00125-016-4043-z · Cited by 31
Li, X., Pan, E., Zhu, J., Xu, L., Chen, X., Li, J., Liang, L., Hu, Y., Xia, J. L., Chen, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21847-3 · Cited by 31
Fuller, S. E., Huang, T., Simon, J., Batdorf, H. M., Essajee, N. M., Scott, M. C., Waskom, C., Brown, J. M., Burke, S. J., Collier, J. J., et al. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00820.2018 · Cited by 33
“Alternatively, PGC-1 is involved in hepatic exercise adaptations as it can 1) increase mitochondrial biogenesis and substrate oxidative capacity (45) and 2) regulate gluconeogenesis (76).”
BackgroundOxidative Stress Induces Phosphoenolpyruvate Carboxykinase Expression in H4IIE Cells
Ito, Y., Saori, O. U. M. I., NAGASAWA, T., & NISHIZAWA, N. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60135 · Cited by 32
Favorit, V., Hood, W. R., Kavazis, A. N., & Skibiel, A. L. (2021) · Journal of Dairy Science · doi:10.3168/jds.2021-20138 · Cited by 32
Rigalli, J. P., Theile, D., Nilles, J., & Weiß, J. (2021) · Cells · doi:10.3390/cells10113137 · Cited by 30
Zhang, J., Henagan, T. M., Gao, Z., & Ye, J. (2011) · Endocrinology · doi:10.1210/en.2010-0828 · Cited by 30
“The transcriptional coactivators for Pepck include cAMP response element-binding protein/P300 (43), transducer of regulated cAMP response element-binding protein 2 (44–46) and PPAR coactivator-1 (31, 32), which promote acetylation of histone proteins in the transcriptional activation of Pepck.”
BackgroundChang, H. C., Kao, C. H., Chung, S. Y., Chen, W.-C., Aninda, L. P., Chen, Y. H., Juan, Y. A., & Chen, S. L. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.009 · Cited by 30
Loss of Hepatic Oscillatory Fed microRNAs Abrogates Refed Transition and Causes Liver Dysfunctions
Maniyadath, B., Chattopadhyay, T., Verma, S. P., Kumari, S., Kulkarni, P., Banerjee, K. K., Lazarus, A., Kokane, S. S., Shetty, T., Anamika, K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.087 · Cited by 30
Wang, L., Yu, J., Zhou, Q., Wang, X., Mukhanova, M., Du, W. J., Sun, L., Pajvani, U. B., & Accili, D. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.013 · Cited by 30
Wilson, R. L., Lampe, K., Gupta, M. K., Duvall, C. L., & Jones, H. N. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23644 · Cited by 30
Structure Guided Design of 5-Arylindazole Glucocorticoid Receptor Agonists and Antagonists
Yates, C. M., Brown, P. J., Stewart, E. L., Patten, C., Austin, R. J. H., Holt, J. A., Maglich, J. M., Angell, D. C., Sasse, R. Z., Taylor, S. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100447c · Cited by 32
Chang, J. H., Lin, K., Shih, C. H., Chang, Y. J., Chung, H., & Chen, S. L. (2006) · Endocrinology · doi:10.1210/en.2005-1317 · Cited by 34
“Later studies have proven its function in the biogenesis of mitochondria, gluconeogenesis, and fatty acid oxidation (3, 4).”
BackgroundOriente, F., Iovino, S., Cabaro, S., Cassese, A., Longobardi, E., Miele, C., Ungaro, P., Formisano, P., Blasi, F., & Bèguinot, F. (2010) · Diabetes · doi:10.2337/db10-0860 · Cited by 30
Retracted
Metadata
- Authors
- Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6852
- Pages
- 131-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1523158326
- Cited by
- 1,821
- References
- 33
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 24 · 2023: 48 · 2022: 48 · 2021: 68 · 2020: 63 · 2019: 74 · 2018: 84 · 2017: 67 · 2016: 78 · 2015: 95 · 2014: 75 · 2013: 98 · 2012: 104
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1, hepatic gluconeogenesis, transcriptional coactivator, fasting, insulin resistance, diabetes mellitus, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, glucocorticoid receptor, HNF4α, cyclic AMP, ob/ob mice, streptozotocin-induced diabetes
- MeSH terms
- Cyclic AMP, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Experimental, DNA-Binding Proteins, Fasting, Gluconeogenesis, Hormones, Insulin, Liver, Male, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Phosphoproteins, Receptors, Glucocorticoid, Receptor, Insulin, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, 3T3 Cells, Rats, Wistar, Mice, Knockout, Response Elements, Amino Acid Motifs, Mice, Rats, Hepatocyte Nuclear Factor 4, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.